.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Chubb
Queensland Health
Julphar
Deloitte
AstraZeneca
Covington
Citi
Express Scripts
McKinsey

Generated: June 24, 2017

DrugPatentWatch Database Preview

TAMOXIFEN CITRATE Drug Profile

« Back to Dashboard

What is the patent landscape for Tamoxifen Citrate, and what generic Tamoxifen Citrate alternatives are available?

Tamoxifen Citrate is a drug marketed by Teva, Roxane, Actavis Labs Fl Inc, Mylan, Pharmachemie, Ivax Sub Teva Pharms, Mayne Pharma, Apotex, and Aegis Pharms. and is included in eleven NDAs.

The generic ingredient in TAMOXIFEN CITRATE is tamoxifen citrate. There are sixteen drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.

Summary for Tradename: TAMOXIFEN CITRATE

Patents:0
Applicants:9
NDAs:11
Suppliers / Packagers: see list10
Bulk Api Vendors: see list47
Clinical Trials: see list891
Patent Applications: see list7,202
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TAMOXIFEN CITRATE at DailyMed

Pharmacology for Tradename: TAMOXIFEN CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL074504-001Apr 28, 2003DISCNNoNo► Subscribe► Subscribe
Aegis Pharms
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL076398-001Mar 31, 2003DISCNNoNo► Subscribe► Subscribe
Mylan
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL074732-002Feb 20, 2003ABRXNoNo► Subscribe► Subscribe
Roxane
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL076027-002Feb 20, 2003DISCNNoNo► Subscribe► Subscribe
Mayne Pharma
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL074858-001Feb 20, 2003ABRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Queensland Health
Fuji
Cipla
Accenture
AstraZeneca
Mallinckrodt
US Department of Justice
Boehringer Ingelheim
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot